Immunology Flashcards

1
Q

What are SPUR features?

A
Serious infections
Persistent infections
Unusual infections
Recurrent infections
(Clinical features suggestive of immunodeficiency)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Commonest form of severe combined immunodeficiency

A

X-linked SCID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Underlying immuno-pathophysiology of X-linked SCID

A

IL-2 receptor mutation; inability to produce T cells and NK cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical presentation of X-linked SCID (4)

A

Unwell by 3 months old
Persistent diarrhoea
Failure to thrive
Infections of all types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Organised collection of activated macrophages and lymphocytes

A

Granuloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Key mediators in granuloma formation (3)

A

IL-12 released by macrophages
gIFN produced by T-cells
TNF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Granulomatous conditions (3)

A

Sarcoidosis
Tuberculosis
Silicosis and other dust diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Manifestations of antibody dysfunction (2)

A

Recurrent bacterial infections

Antibody-mediated immune diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Examples of antibody deficiencies (2)

A

Common variable immune deficiency (CVID)

Selective IgA deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Bruton’s agammaglobulinaemia?

A

An X-linked primary deficiency of antibody production where patients have no B cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Causes of secondary hypogammaglobulinaemia (2)

A

Protein loss e.g. nephrotic syndrome

Lymphoproliferative disease e.g. myeloma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Type I hypersensitivity

A

IgE-mediated e.g. anaphylaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Type II hypersensitivity

A

Antibody-mediated direct cell-killing, e.g. autoimmune haemolytic anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Type III hypersensitivity

A

Immune complex-mediated e.g. SLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Type IV hypersensitivity

A

Delayed type, T-cell mediated e.g. graft versus host disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can antibody lead to direct cell killing? (3)

A

Activation of complement via the classical pathway leading to:

a) opsonization (optimises phagocytosis)
b) formation of the membrane attack complex, causing lysis
c) recruitment of other immune cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What activates the alternative complement pathway?

A

LPS on microbial surfaces

18
Q

What does complement deficiency predispose to?

A

Bacterial infection especially meningitis

19
Q

What types of cell do NK cells target? (2)

A

Cells which lack MHC molecules on surface; especially viruses and cancer cells

20
Q

What are Toll-like receptors? (2)

A

Receptors on phagocytes providing innate recognition of pathogens; activation leads to release of pro-inflammatory cytokines

21
Q

What are adalimumab and etanercept? What is their mechanism of action?

A

TNF-inhibitors used in chronic inflammatory conditions such as rheumatoid arthritis and Crohns disease. Inhibit TNF, thus preventing release of pro-inflammatory cytokines

22
Q

What is the main risk/side effect of adalimumab?

A

Reactivation of tuberculosis

23
Q

Mechanism of hyperacute graft rejection

A

Type II hypersensitivity- pre-formed antibody and complement activation

24
Q

Timescale and mechanism of acute graft rejection

A

5-30 days; Type IV hypersensitivity (T cells)

25
Q

What is the drug target of cyclosporin?

A

Calcineurin. Inhibition helps prevent lymphocyte activation

26
Q

What is the first antibody to be produced in the immune response?

A

IgM

27
Q

Vaccination stimulates the production of…

A

Memory T cells

28
Q

Main types of vaccine

A

Inactivated vaccines

Live attenuated vaccines

29
Q

Disadvantages of inactivated vaccines (2)

A

Require multiple/booster injections

Require adjuvants to boost immunogenecity

30
Q

Constituents of the 5-in-1 vaccine

A
Diphtheria
Tetanus
Pertussis
Polio
HiB
31
Q

What type of vaccine is the 5-in-1? When is this given?

A

Inactivated vaccines. 8, 12 and 16 weeks
(at 3 years and 4 months, given again minus HiB)
(at 14 years given again minus HiB and pertussis)

32
Q

Advantages of live attenuated vaccines (3)

A

Elicits antibody and T cell responses
Gives strong response
Usually only one dose required

33
Q

Example of a live attenuated vaccine given at one year

A

MMR

34
Q

How does the lectin pathway of complement work?

A

Proteins such as MBL coat sugars on the surface of bacteria, thus activating the complement cascade and helping the bacteria be eliminated

35
Q

Why is the “5-in-1” vaccine given at 3 months, 4 months and 3 years?

A

In order to boost immunity- 5-in-1 vaccine are inactivated and hence have poor immunogenecity

36
Q

How do live attenuated vaccines work?

A

pathogen is made virulent, but is still live and replicating, and hence is a good immunogen

37
Q

Which antibody is mostly generated during secondary exposure to a pathogen?

A

IgG

there is also smaller levels of IgM

38
Q

How does IgA selective deficiency usually present?

A

Most are asymptomatic and will not be detected

39
Q

The main risks of TNF inhbitors is are…

A

Granulomatous infections, fungal infections

40
Q

Anti-TNFs represent a form of…

A

Passive immunisation

41
Q

How does imiquimod work?

A

Activates TLR-8 in macrophages/dendritic cells, leading to activation of these cells. In skin cancer (BCC) it increases infiltration of immune cells into the skin, where they can detect abnormal cancer cells